Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
Fax 1.858.633.0166    Email 
menu1 Home Products Ordering Company Help menu7
   MyBioSource rightarrow Antibody rightarrow F7 rightarrow Polyclonal F7  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Menu separator
Monoclonal Antibody Monoclonal Antibody
Polyclonal Antibody Polyclonal Antibody
Secondary Antibody Secondary Antibody
Antigen Antigen
Biochemical Biochemical
cDNA Clone cDNA Clone
Peptide Peptide
Recombinant/Purified Protein Rec./Purified Protein

Custom ELISA Kit Custom ELISA Kit
Custom Protein Custom Protein
Custom Antibody Custom Antibody
Antibody Matched Pairs Antibody Matched Pairs
Antibody & Corresponding Blocking Peptide Pairs Antibody Peptide Pairs
Phospho-Specific Antibodies Phospho Antibodies
Products by Disease Products by Disease
Products by Pathway Products by Pathway
Products by Tissue Products by Tissue

arrow Advanced Search
arrow Submit Technical Q&A
arrow International Distributors
arrow Contact Us
Our Best Sellers moreseparator
 • Streptolysin (slo) Antibody
 • Stomatin Like Protein 2 (SLP-2) ELISA Kit
 • IL-4 ELISA Kit
 • Vascular cell adhesion molecule 1 (VCAM1) Recombinant Protein
 • TNFRSF17 Recombinant Protein
 • Glutathione (GSH) Antibody
 • Glutamate Decarboxylase 65 (Gad2) Antibody
 • immunoglobulin heavy constant gamma 1 (G1m marker) (IGHG1) ELISA Kit
 • Urease subunit alpha (ureC) Recombinant Protein
 • MYH8 Antibody
 • dihydrodiol dehydrogenase (AKR1C1) Antibody
 • Prothrombin precursor Antibody
 • SGK1 cDNA Clone
 downarrow more ...
DatasheetFull DatasheetPrinter Friendly DatasheetPrint This DatasheetAdd to Compare ListHave Questions? Ask UsRequest for a Quotation today

anti-F7 antibody :: Sheep Factor VII Polyclonal Antibody

Scan QR to view Datasheet Catalog #    MBS512048 anti-F7 antibody
Unit / Price
0.2 mg  /  $375 +1 FREE 8GB USB
 Go to:   rightarrow  Product Names   rightarrow Product Info   rightarrow Accession #s   rightarrow Product Desc   rightarrow Diseases/Tissues/Pathways   rightarrow Applications   rightarrow References 
 Product Name   

Factor VII (F7), Polyclonal Antibody

★Popular Item★
 Also Known As   

Sheep anti-human Factor VII (F.VII), Peroxidase Conjugated IgG

 Product Synonym Names    Factor VII, human
 Product Gene Name   

anti-F7 antibody

[Similar Products]
 Research Use Only    For Research Use Only. Not for use in diagnostic procedures.
Table BarTOPTable Bar
 Chromosome Location    Chromosome: 13; NC_000013.10 (113760105..113774995). Location: 13q34
 OMIM    227500
 3D Structure    ModBase 3D Structure for P08709
Section Bar
 Clonality    Polyclonal
 Host    Sheep
Section Bar
 Specificity    Prior to conjugation, this antibody was specific for F.VII as demonstrated by immunoelectrophoresis and ELISA.
 Purity/Purification    Peroxidase conjugated IgG.
Vial containing ml of whole IgG conjugated to horseradish peroxidase (HRP) through carbohydrate groups. Total protein is 0.2 mg.
 Form/Format    IgG-HRP conjugate as a clear, slightly red-brown liquid.
 Concentration    IgG-HRP concentration is mg/ml, determined by absorbance using an extinction coefficient (E1%280) of 14. (lot specific)
Section Bar
 Immunogen    Human F.VII purified from plasma.
 Buffer    A buffered stabilizer solution containing 50% (v/v) glycerol.
Section Bar
 Preparation and Storage    Store between -10 and -20 degree C. Product will become viscous but will not freeze. Avoid storage in frost-free freezers. Keep vial tightly capped. Allow product to warm to room temperature and gently mix before use. Avoid exposure to sodium azide as this is an inhibitor of peroxidase activity.
 Other Notes    Small volumes of anti-F7 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Table BarTOPTable Bar

Related Product Information for anti-F7 antibody

   Factor VII (F.VII, also known as Stable Factor and Proconvertin) is a vitamin K-dependent glycoprotein produced in the liver. Plasma concentration of F.VII is normally ~0.5 ug/ml (10 nM) in plasma. A deficiency of F.VII is associated with bleeding in a clinical pattern similar to haemophilia, but is inherited as an autosomal recessive trait. The deficiency can be characterized by a quantitative (low activity and low antigen) or a qualitative (low activity and normal antigen) defect in F.VII function. In its zymogen form F.VII is a single chain molecule of ~50 kDa. It contains two EGF-like domains and an amino-terminal domain containing 10 gamma-carboxyglutamic acid (Gla) residues. These Gla residues allow F.VII to bind divalent metal ions and participate in calcium-dependent binding interactions. F.VII and activated F.VII (F.VIIa) bind to tissue factor exposed at the site of vascular injury. F.IXa, F.Xa or F.VIIa rapidly activate tissue factorbound F.VII to F.VIIa in the presence of calcium and phospholipid. Thrombin and F.XIIa are able to activate F.VII in the fluid phase in the absence of cofactors. The activation of the single chain zymogen F.VII occurs by proteolysis after residue Arg152, resulting in a twochain active serine protease consisting of a 30 kDa heavy chain and an 18 kDa light chain. In complex with tissue factor, phospholipid and calcium, F.VIIa is able to activate F.X and F.IX. Free F.VIIa in plasma is remarkably stable, but the activity of F.VIIa/TF complex is regulated by Tissue Factor Pathway Inhibitor (TFPI) in the presence of F.Xa, and also by Antithrombin (ATIII) in the presence of heparin1-3.
NCBI/Uniprot data below describe general gene information for F7. It may not necessarily be applicable to this product.
 NCBI GI #    180334
 NCBI GeneID    2155
Section Bar
 UniProt Primary Accession #    P08709 [Other Products]
 UniProt Secondary Accession #    Q14339; Q5JVF1; Q5JVF2; Q9UD52; Q9UD53; Q9UD54; B0YJC8 [Other Products]
 UniProt Related Accession #    P08709; Q6TDG2; Q9UMU6 [Other Products]
 Molecular Weight    51,594 Da [Similar Products]
Table BarTOPTable Bar
 NCBI Official Full Name    factor VII
 NCBI Official Synonym Full Names    coagulation factor VII (serum prothrombin conversion accelerator)
 NCBI Official Symbol    F7 [Similar Products]
 NCBI Protein Information    coagulation factor VII; SPCA; eptacog alfa; proconvertin; OTTHUMP00000018733; OTTHUMP00000018734; FVII coagulation protein; serum prothrombin conversion accelerator
 UniProt Protein Name    Coagulation factor VII
 UniProt Synonym Protein Names   
Proconvertin; Serum prothrombin conversion accelerator
 Protein Family    Factor VIII intron 22 protein
 UniProt Gene Name    F7 [Similar Products]
 UniProt Entry Name    FA7_HUMAN
Section Bar
 NCBI Summary for F7    This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Alternative splicing of this gene results in 2 transcripts. Defects in this gene can cause coagulopathy. [provided by RefSeq]
Section Bar
 UniProt Comments for F7    Function: Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.

Catalytic activity: Selective cleavage of Arg-|-Ile bond in factor X to form factor Xa.

Subunit structure: Heterodimer of a light chain and a heavy chain linked by a disulfide bond.

Subcellular location: Secreted.

Tissue specificity: Plasma.

Post-translational modification: The vitamin K-dependent, enzymatic carboxylation of some glutamate residues allows the modified protein to bind calcium.The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains.

Involvement in disease: Defects in F7 are the cause of factor VII deficiency (FA7D) [

MIM:227500]. A hemorrhagic disease with variable presentation. The clinical picture can be very severe, with the early occurrence of intracerebral hemorrhages or repeated hemarthroses, or, in contrast, moderate with cutaneous-mucosal hemorrhages (epistaxis, menorrhagia) or hemorrhages provoked by a surgical intervention. Finally, numerous subjects are completely asymptomatic despite very low factor VII levels. Ref.11 Ref.18 Ref.19 Ref.20 Ref.22 Ref.24 Ref.25 Ref.26 Ref.27 Ref.28 Ref.29 Ref.30 Ref.31 Ref.32 Ref.35 Ref.36 Ref.37 Ref.39 Ref.40 Ref.41 Ref.42 Ref.43 Ref.44 Ref.45

Pharmaceutical use: Available under the names Niastase or Novoseven (Novo Nordisk). Used for the treatment of bleeding episodes in hemophilia A or B patients with antibodies to coagulation factors VIII or IX.

Sequence similarities: Belongs to the peptidase S1 family.Contains 2 EGF-like domains.Contains 1 Gla (gamma-carboxy-glutamate) domain.Contains 1 peptidase S1 domain.
Table BarTOPTable Bar

Product References and Citations for anti-F7 antibody

   1. Rao LVM, Bajaj SP, Rapaport SI; Activation of Human Factor VII During Clotting in Vitro; Blood 65, pp 218-226, 1985.
2. Lawson, JH, Butenas S, Ribarik N, Mann KG; Complex-dependent Inhibition of Factor VIIa by Antithrombin III and Heparin; JBC 268 pp 767-770, 1993.
3. Nemerson Y, in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 81-93, J.B. Lippincott Co., Philadelphia PA, USA, 1994.
Section Bar
 Research Articles on F7    1. Factor VII deficiency in Korea showed recurrent mutations in this population and suggested genotype-phenotype correlations.
Table BarTOPTable Bar
 Precautions    All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
 Disclaimer    While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Table BarTOPTable Bar
Products associated with anti-F7 antibodyPathways associated with anti-F7 antibody
 Reference Product  PubMed Publications
 F10 antibody  >17 publications with F7 and F10
 GGCX antibody  >4 publications with F7 and GGCX
 Products by Pathway  Pathway Diagram
 Blood Clotting Cascade Pathway antibodies  Blood Clotting Cascade Pathway Diagram
 Circadian Clock Pathway antibodies  Circadian Clock Pathway Diagram
 Complement And Coagulation Cascades Pathway antibodies  Complement And Coagulation Cascades Pathway Diagram
 Complement And Coagulation Cascades Pathway antibodies  Complement And Coagulation Cascades Pathway Diagram
 Complement And Coagulation Cascades Pathway antibodies  Complement And Coagulation Cascades Pathway Diagram
 Extrinsic Pathway antibodies  Extrinsic Pathway Diagram
 Formation Of Fibrin Clot (Clotting Cascade) Pathway antibodies  Formation Of Fibrin Clot (Clotting Cascade) Pathway Diagram
 Gamma-carboxylation Of Protein Precursors Pathway antibodies  Gamma-carboxylation Of Protein Precursors Pathway Diagram
 Gamma-carboxylation, Transport, And Amino-terminal Cleavage Of Proteins Pathway antibodies  Gamma-carboxylation, Transport, And Amino-terminal Cleavage Of Proteins Pathway Diagram
 Hemostasis Pathway antibodies  Hemostasis Pathway Diagram
Diseases associated with anti-F7 antibodyOrgans/Tissues associated with anti-F7 antibody
 Disease Name  Pubmed Publications
 Neoplasms Antibodies  >69 publications with F7 and Neoplasms
 Female Urogenital Diseases Antibodies  >30 publications with F7 and Female Urogenital Diseases
 Blood Coagulation Disorders Antibodies  >28 publications with F7 and Blood Coagulation Disorders
 Hemorrhagic Disorders Antibodies  >28 publications with F7 and Hemorrhagic Disorders
 Factor VII Deficiency Antibodies  >27 publications with F7 and Factor VII Deficiency
 Heart Diseases Antibodies  >25 publications with F7 and Heart Diseases
 Drug Toxicity Antibodies  >15 publications with F7 and Drug Toxicity
 Thrombosis Antibodies  >15 publications with F7 and Thrombosis
 Kidney Diseases Antibodies  >13 publications with F7 and Kidney Diseases
 Liver Diseases Antibodies  >11 publications with F7 and Liver Diseases
 Organ/Tissue Name  Pubmed Publications
 Brain Antibodies  >136 publications with F7 and Brain
 Liver Antibodies  >24 publications with F7 and Liver
 Testis Antibodies  >4 publications with F7 and Testis
 Mammary Gland Antibodies  >1 publications with F7 and Mammary Gland
Table BarTOPTable Bar
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions